Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeksParul Patel, Ana Milinkovic, Richard Grove, et al.Biofabrication|June 21, 2019
3D printed coaxial nozzles for the extrusion of hydrogel tubes toward modeling vascular endotheliumS Cem Millik, Ashley M Dostie, Dylan G Karis, et al.Circulation. Cardiovascular Interventions|May 23, 2025
Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic StenosisMichael McKenna, Niromila Nadarajan, Sumanto Mukhopadhyay, et al.European Heart Journal. Cardiovascular Imaging|September 5, 2025
Myocardial Remodelling in Aortic Regurgitation: Time to Think Beyond Volumes and Function?George D Thornton, Michael McKenna, Jonathan Bennett, et al.Interventional Pain Medicine|September 6, 2024
Guidelines for composing and assessing a paper on the treatment of pain: A practical application of evidence-based medicine principles to a cost-effectiveness analysis of the MINT randomized clinical trialsReza Ehsanian, Daniel C Malone, Johan Hambraeus, et al.The Pediatric Infectious Disease Journal|February 4, 2026
Model-informed Dolutegravir Dose Selection in Pediatrics With First-generation INSTI ResistanceHardik Chandasana, Ann M Buchanan, Cassidy A Henegar, et al.Heart (British Cardiac Society)|December 26, 2023
Predictors of outcome in patients with moderate mixed aortic valve diseaseKush P Patel, Michael McKenna, George D Thornton, et al.The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|November 21, 2025
Effects of mindfulness training on sustained attention and mind-wandering in older adults: Results from the HealthyAgers randomized controlled trialMegan Fisher, Madhura Phansikar, James Teng, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2025
Efficacy and Safety of the Two-Drug Regimen Dolutegravir-Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-Label, Phase 3b TrialThanyawee Puthanakit, Linda Aurpibul, Monica Lopez, et al.Journal of Applied Clinical Medical Physics|June 24, 2015
Potential of 3D printing technologies for fabrication of electron bolus and proton compensatorsWei Zou, Ted Fisher, Miao Zhang, et al.Pageof 6